Skip to main content

What the FDA labels say about taking them together

Cobicistat and erythromycin

Cobicistat's FDA label of February 10, 2026 names erythromycin in its drug interactions section; the erythromycin labels PlainMeds reads (4) do not name cobicistat.

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.).

What does the cobicistat label say about erythromycin?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Antibacterials (macrolide or ketolide antibiotics): clarithromycin erythromycin telithromycin; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ clarithromycin ↑ erythromycin ↑ telithromycin ↑ cobicistat ↑ atazanavir ↑ darunavir; Clinical Comment: Consider alternative antibiotics with concomitant use of TYBOST coadministered with atazanavir or darunavir.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the erythromycin label say about cobicistat?

Erythromycin's label (effective August 1, 2024) and its 3 other brand-application labels do not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
38Erythromycin generic labelers
CobicistatErythromycin
Labeled forHIVBacterial infections, Acne
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$1.96 per tablet 250 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?